Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any fatal infantile encephalocardiomyopathy in which the cause of the disease is a mutation in the SCO2 gene.
Features include always present findings: Encephalopathy, Peripheral axonal neuropathy, Hearing loss (hearing impairment), and Strabismus and others; and very common findings: Increased circulating lactate concentration, Enlarged liver (hepatomegaly), Brain atrophy, and Respiratory failure and others. 100 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 32 | Encephalopathy, Peripheral axonal neuropathy, Abnormal brainstem MRI signal intensity |
Muscles | 18 | Myopathy, Muscle weakness, Shrinkage of the cerebellum (cerebellar atrophy) |
Lungs and breathing | 5 | Respiratory failure, Respiratory distress, Dyspnea |
Eyes | 4 | Strabismus, Nystagmus, Ptosis |
Heart and blood vessels | 4 | Cardiac arrest, Right ventricular hypertrophy, Heart murmur |
Head and neck | 4 | Microcephaly, High palate, Facial-lingual fasciculations |
Arms and legs | 4 | Hypoplastic toenails, Hand muscle atrophy, Limb hypertonia |
Lab test results | 3 | Increased circulating lactate concentration, Decreased activity of mitochondrial complex IV, Abnormal circulating creatine kinase concentration |
Digestive system | 3 | Enlarged liver (hepatomegaly), Jaundice, Feeding difficulties |
Ears | 1 | Hearing loss (hearing impairment) |
Metabolism | 1 | Metabolic acidosis |
Growth and development | 1 | Failure to thrive |
SCO2 function has not been fully characterized.
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 is associated with mutations in the SCO2 gene on chromosome 22.
Genetic testing for SCO2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 55 always present features, 9 very common features, 32 common features.
No clinical trials have been registered for cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1.
1 publication has been identified in PubMed for cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1. Research spans Epidemiology / Natural History (100%).
Idárraga GDO (2025). [PMID: 40080775](https://pubmed.ncbi.nlm.nih.gov/40080775/). *JBRA Assist Reprod*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 21, 2026, 12:30 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1